FDA clears J&J drug for tough-to-treat TB – MarketWatch
![]() San Francisco Chronicle |
FDA clears J&J drug for tough-to-treat TB
MarketWatch Fewer than 100 Americans have MDR-TB, according to J&J, but FDA approval is likely to strengthen the chances for approval in regions where the disease is more prevalent, including India, China and Eastern Europe. However, the drug’s potential side … FDA backs the first new drug for TB in 40 yearsPress Herald |


